Literature DB >> 18803950

Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.

Olga Rafikova1, Eman M Salah, Stevan P Tofovic.   

Abstract

Oxidative stress, that is, overproduction of reactive oxygen species and reduced antioxidant system activity, is implicated in the pathogenesis of diabetic complications; and therefore, superoxide dismutase (SOD) mimetic tempol should be protective in diabetic kidney. However, the effects of tempol in metabolic syndrome-associated renal injury have not been thoroughly examined. In this study, we examined the effects of 9 weeks of treatment with tempol on metabolic status, renal oxidative stress, and kidney function and structure in obese, diabetic, hypertensive ZSF(1) rats and their nondiabetic, hypertensive, lean littermates. The obese rats had significantly reduced total SOD and catalase activity, increased peroxidase activity and lipid peroxidation, and higher level of protein oxidation in renal cortical tissue compared with their lean littermates. These changes were accompanied by renal injury (proteinuria; reduced excretory function; and markedly increased glomerular and interstitial inflammation, proliferation, and collagen IV synthesis). Tempol treatment slightly increased total SOD activity, significantly reduced lipid peroxidation and peroxidase activity, but had no effect on catalase and protein oxidation. Tempol had no effects on blood pressure, renal hemodynamics and excretory function, and proteinuria in obese rats, yet improved insulin sensitivity and reduced renal inflammatory, proliferative, and fibrotic changes. Because tempol possesses no catalase activity and, in diabetes, not only SOD but also catalase is inhibited, it is possible that the toxicity of hydrogen peroxide (H(2)O(2)) remains unaltered under tempol treatment. This study suggests that superoxide and H(2)O(2) may have distinct roles in the pathogenesis of diabetic renal injury, with superoxide mainly being involved in inflammatory, proliferative, and fibrotic changes, and H(2)O(2) in glomerular hemodynamics and proteinuria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803950     DOI: 10.1016/j.metabol.2008.05.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

Review 1.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

2.  Knockouts of SOD1 and GPX1 exert different impacts on murine islet function and pancreatic integrity.

Authors:  Xiaodan Wang; Marko Z Vatamaniuk; Carol A Roneker; Matthew P Pepper; Liangbiao G Hu; Rebecca A Simmons; Xin Gen Lei
Journal:  Antioxid Redox Signal       Date:  2010-09-29       Impact factor: 8.401

3.  Sitagliptin augments angiotensin II-induced renal vasoconstriction in kidneys from rats with metabolic syndrome.

Authors:  David S Tofovic; Victor P Bilan; Edwin K Jackson
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-30       Impact factor: 2.557

4.  Deletion of UCP1 enhances ex vivo aortic vasomotor function in female but not male mice despite similar susceptibility to metabolic dysfunction.

Authors:  Nathan C Winn; Zachary I Grunewald; Michelle L Gastecki; Makenzie L Woodford; Rebecca J Welly; Stephanie L Clookey; James R Ball; T'Keaya L Gaines; Natalia G Karasseva; Jill A Kanaley; Harold S Sacks; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

Review 5.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

6.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

7.  Plasmin activates epithelial Na+ channels by cleaving the gamma subunit.

Authors:  Christopher J Passero; Gunhild M Mueller; Helbert Rondon-Berrios; Stevan P Tofovic; Rebecca P Hughey; Thomas R Kleyman
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

8.  The ZDSD rat: a novel model of diabetic nephropathy.

Authors:  Richard G Peterson; Charles Van Jackson; Karen M Zimmerman
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

9.  Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction.

Authors:  Stevan P Tofovic; Eman M Salah; Glenn J Smits; Eric T Whalley; Barry Ticho; Aaron Deykin; Edwin K Jackson
Journal:  J Pharmacol Exp Ther       Date:  2015-11-19       Impact factor: 4.030

Review 10.  NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease.

Authors:  Liang-Jun Yan
Journal:  Biomolecules       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.